β-Phenylpyruvate induces long-term neurobehavioral damage and brain necrosis in neonatal mice

Behavioural Brain Research

Volumn 143, Issue 1, 2003, Pages 1-5

  Gazit, Vered ^a   Ben Abraham, Ron ^b   Pick, Chaim G ^c   Katz, Yeshayahu ^a,d  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^b TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

^c TEL AVIV UNIVERSITY   (Israel)

^d HAEMEK MEDICAL CENTER   (Israel)

Author keywords

Apoptosis; Brain damage; Eight arm maze; Glucose; Phenylketonuria; Phenylpyruvate

Indexed keywords

GLUCOSE; PHENYLPYRUVIC ACID; SODIUM CHLORIDE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BEHAVIOR DISORDER; BODY WEIGHT; BRAIN NECROSIS; BRAIN REGION; CONTROLLED STUDY; HIPPOCAMPUS; HISTOPATHOLOGY; HYPOGLYCEMIA; MAZE TEST; MOUSE; NEUROLOGIC DISEASE; NEUROTOXICITY; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; SPATIAL MEMORY; WATER DEPRIVATION;

EID: 0038690564     PISSN: 01664328     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-4328(03)00075-5     Document Type: Article

References (20)

1. Anonymous. Brain damage by neonatal hypoglycemia. Lancet 1989;1:882-3 [editorial].
2. Auer R.N. Progress review: hypoglycemic brain damage. Stroke. 17:1986;699-708.
3. Boyle P.J., Kempers S.F., O'Connor A.M., Nagy R.J. Brain glucose uptake and unawareness of hypoglycemia in patients with insulin-dependent diabetes mellitus. N. Engl. J. Med. 333:1995;1726-1731.
4. Dodge P.R., Mancall E.L., Crawford J.D., Knapp J., Paine R.S. Hypoglycemia complicating treatment of phenylketonuria with a phenylalanine-deficient diet. Report of two cases. N. Engl. J. Med. 260:1959;1104-1111.
5. Gavrieli Y., Sherman Y., Ben-Sasson S.A. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J. Cell Biol. 119:1992;493-501.
6. Gazit V., Katz Y. Phenylpyruvate-induced hypoglycemia is relevant to mental retardation in phenylketonuria. Neurosci. Lett. Suppl. 48:1997;S18. [abstract].
7. Kamaryt J., Mrskoš A. Is the inhibition of glutamic-pyruvic transaminase by phenylalanine one of the causes of hypoglucosemia in phenylketonurics? Acta. Univ. Carol. Med. Monogr. 56:1973;187-190.
8. Kaufman S. An evaluation of the possible neurotoxicity of metabolites of phenylalanine. J. Pediatr. 114:1989;895-900.
9. Levy H.L. Phenylketonuria: old disease, new approach to treatment. Proc. Natl. Acad. Sci. U.S.A. 96:1999;1811-1813. [editorial].
10. Lucas A., Morley R., Cole T.G. Adverse neurodevelopmental outcome of moderate neonatal hypoglycemia. BMJ. 297:1988;1304-1308.
11. Mrskoš A., Kaniová V., Podhradská O., Drášilová L., Snopková J. Impaired glucose homeostasis in phenylketonurics. Acta. Univ. Carol. Med. Monogr. 56:1973;197-199.
12. Olton DS. Spatial memory. Sci Am 1977;276(6):82-4, 89-94, 96, 98.
13. Olton D.S., Samuelson R.J. Remembrance of place passed: spatial memory in rats. J. Exp. Psychiatry. 2:1976;97-116.
14. Pick C.G., Yanai J. Eight arm maze for mice. Int. J. Neurosci. 21:1983;63-66.
15. Scriver CR, Kaufman S, Eisensmith RC, Woo SLC. The hyperphenylalaninemias. In: Scriver CR, Beaudet AL, Sly WS, Valle D, editors. The metabolic and molecular bases of inherited disease, vol. 1. 7th ed. New York: McGraw-Hill; 1995. p. 1015-75.
16. Sener A., Welsh M., Lebrun P., Garcia-Morales P., Saceda M., Malaisse-Lagae F.et al. Mechanism of 3-phenylpyruvate-induced insulin release. Secretory, ionic and oxidative aspects. Biochem. J. 210:1983;913-919.
17. Shyi S., Yanai J., Pick C.G. Directional consistency: determinant of learned maze performance of five mice strains. Behav. Process. 32:1994;117-132.
18. Sieber F.E., Traystman R.J. Special issues: glucose and the brain. Crit. Care Med. 20:1992;104-114.
19. Weber G. Inhibition of human brain pyruvate kinase and hexokinase by phenylalanine and phenylpyruvate: possible relevance to phenylketonuric brain damage. Proc. Natl. Acad. Sci. U.S.A. 63:1969;1365-1369.
20. Ziyai F., Wong P.W.K., Justice P., Michals K. Protein-induced hypoglycemia in a phenylketonuric patient. J. Pediatr. 92:1978;681-682.